Bora-Pharmaceuticals-Header Bora-Pharmaceuticals-Header

X

Find Clinical Drug Development Pipelines & Deals | PipelineProspector

Loading...

All Data

Filters Filter
×
FILTER:
filter News Type
    filter Company
      filter Product Type
        filter Deal Size
          filter Upfront Payment

            Active Filter(s):

            Product Type

            Companies

            Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

            Lead Product(s): Glucarpidase

            Therapeutic Area: Pharmacology/Toxicology Product Name: Voraxaze

            Highest Development Status: Approved Product Type: Large molecule

            Partner/Sponsor/Collaborator: Serb

            Deal Size: Undisclosed Upfront Cash: Undisclosed

            Deal Type: Acquisition March 02, 2021

            Details:

            BTG Specialty Pharmaceuticals has a portfolio of market-leading emergency care products, including CroFab®, Voraxaze®, and DigiFab®.